SEC Comment Letter 0000000000-25-003742 to CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
Date: April 8, 2025 · CIK: 0001187953 · Accession: 0000000000-25-003742
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-286346
Letter
Re: Creative Medical Technology Holdings, Inc. Registration Statement on Form S-3 Filed April 2, 2025 File No. 333-286346 Dear Timothy Warbington:
April 8, 2025
Timothy Warbington Chief Executive Officer Creative Medical Technology Holdings, Inc. 211 E Osborn Road Phoenix, AZ 85012
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tyler Howes at 202-551-3370 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Zev M. Bomrind, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> April 8, 2025 Timothy Warbington Chief Executive Officer Creative Medical Technology Holdings, Inc. 211 E Osborn Road Phoenix, AZ 85012 Re: Creative Medical Technology Holdings, Inc. Registration Statement on Form S-3 Filed April 2, 2025 File No. 333-286346 Dear Timothy Warbington: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tyler Howes at 202-551-3370 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Zev M. Bomrind, Esq. </TEXT> </DOCUMENT>